The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Open Offer

2 Nov 2018 07:00

RNS Number : 1133G
Imaginatik PLC
02 November 2018
 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR"). Prior to publication, certain information contained within this Announcement was deemed to constitute inside information for the purposes of Article 7 of MAR

 

Imaginatik plc

("Imaginatik" or "the Company")

 

Launch of Underwritten Open Offer

 

On 26 October 2018, Imaginatik plc (AIM: IMTK) plc, the #1 ranked leader in corporate innovation management was pleased to announce an underwritten Open Offer. Today, 2 November it will post a document to Qualifying Shareholders (the "Circular") regarding an Open Offer of 22,961,687 New Ordinary Shares at 1.1 pence ("the Issue Price") to raise up to approximately £252,578 (before expenses). The Issue Price represents a discount of 41.33 per cent to the closing price on the 31 October 2018.

 

Qualifying Shareholders will have a Basic Entitlement of 6 Open Offer Share for every 9 Existing Ordinary Shares held and will also have the opportunity to apply for additional shares under the Excess Application Facility.

 

 

Background to, and reasons for the Open Offer

 

On 26 October 2018 the Company announced a series of measures designed to restore the trading of the Company's shares on AIM, to strengthen the finances of the Company, and to provide a stable and robust basis for the future development of the Company's operations.

 

The series of measures announced on the 26 October 2018 included a placing of 14,545,455 new ordinary shares of 0.002 pence each (the "Placing") in the capital of the Company, at a price of 1.1p (the "Placing Price"), representing approximately 29.7 per cent of the enlarged issued ordinary share capital of the Company, with Eight Capital Partners Plc ("Eight Capital"), an investment vehicle listed on the NEX Exchange Growth Market.

 

The Company has also issued £90,000 of new, unsecured, convertible loan notes ("CLNs") to Eight Capital. The CLNs have a term of three years and an annual coupon of 7.5 per cent. 

 

The funds raised from the Open Offer together with the funds raised as part of the Placing announced on 26 October 2018 will partly be used to repay a loan and to provide additional working capital.

 

Effects of the Open Offer

 

Upon Admission, and assuming full take up of the Open Offer Entitlements, the Enlarged Issued Share Capital is expected to be 71,949,673 Ordinary Shares. On this basis, the New Ordinary Shares will represent approximately 31.91 per cent. of the Company's Enlarged Issued Share Capital.

 

Following the issue of the New Ordinary Shares pursuant to the Open Offer, assuming full take up of the Open Offer Entitlements, Qualifying Shareholders who do not take up any of their Open Offer entitlements will suffer a dilution of 31.91 per cent. to their interests in the Company.

 

The Directors have concluded that proceeding with the Open Offer is the most suitable option available to the Company for raising additional funds through the issue of New Ordinary Shares and that issuing the New Ordinary Shares at a discount is fair and reasonable so far as all existing Shareholders are concerned.

 

 

 

 

 

OPEN OFFER STATISTICS

 

Number of Existing Ordinary Shares in issue at the date of this document

48,987,986

Number of Existing Ordinary Shares in issue at the Record Date

34,442,531

Issue Price per New Ordinary Share

1.1 pence

Open Offer Entitlement

6 Open Offer Shares

for every 9 Existing

Ordinary Shares

Number of Open Offer Shares*

 22,961,687

Open Offer Shares as a percentage of the Enlarged Issued Share Capital*

31.91 per cent.

Proceeds of the Open Offer

£252,578.56

Enlarged Issued Share Capital*

71,949,673

ISIN for Open Offer Entitlements

GB00BD3S3T18

ISIN for Excess Open Offer Entitlements

GB00BD3S3S01

ISIN for Existing ordinary Shares and, following Admission, the New

GB00BFMDJC60

Ordinary Shares

 

* Assuming take-up in full of the Open Offer by Qualifying Shareholders.

 

 

Settlement and dealing

 

In due course application will be made for the Open Offer Shares to be admitted to trading on AIM and Admission is expected to become effective and that dealings will commence at 8.00 a.m. on 28 November 2018.

 

The Open Offer Shares will rank, pari passu, in all respects with the Existing Ordinary Shares, including the right to receive all dividends and other distributions declared on or after the date on which they are issued. It is expected that CREST accounts will be credited with entitlements to the New Ordinary Shares as soon as practicable after 8.00 a.m. on the day of Admission and that share certificates (where applicable) will be despatched as soon as practicable after Admission.

 

 

Underwriting Commitment

 

On 1 November 2018, Imaginatik and Peterhouse entered into an Underwriting Commitment under which Peterhouse has agreed severally to procure subscribers for, or, failing which, that Peterhouse shall introduce investors who themselves shall subscribe for (in proportion to their underwriting commitment), New Ordinary Shares to the extent not taken up under the Open Offer in each case at the Issue Price.

 

 

Recommendation

 

The Directors consider the Open Offer to be in the best interests of the Company and its Shareholders as a whole. As the Company is in a close period the Directors are not able to trade in Imaginatik shares including participation in the Open Offer at this stage, if the Company ceases to be in a close period within the Open Offer timetable it is their intention to participate in the Open Offer.

 

The Directors of the Company accept responsibility for the content of this announcement.

 

Capitalised terms not defined in this Application Form shall have the same meanings as set out in the Circular.

 

A copy of the Circular post to Qualifying Shareholders together with the application form can be downloaded from the Company's website: www.imaginatik.com

 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

 

Open Offer Record Date

6.00 p.m. on 26 October 2018

Announcement of the Open Offer

2 November 2018

Date of this document and of the posting of this document, and Application Forms

2 November 2018

Date Existing Ordinary Shares marked 'ex-entitlement' by the London Stock Exchange

8.00 a.m. on 2 November 2018

Open Offer Entitlements and Excess Open Offer Entitlements credited to CREST stock accounts of Qualifying CREST Shareholders

8.00 a.m. on 5 November 2018 or as soon possible thereafter

Recommended latest time and date for requesting withdrawal of Open Offer Entitlements and Excess Open Offer Entitlements from CREST

4.30 p.m. on 21 November 2018

Latest time and date for depositing Open Offer Entitlements and Excess Open Offer Entitlements into CREST

3.00 p.m. on 23 November 2018

Latest time and date for splitting Application Forms (to satisfy bona fide market claims in relation to Open Offer Entitlements only)

3.00 p.m. on 23 November 2018

Latest time and date for receipt of completed Application Forms and payment in full under the Open Offer or settlement of the relevant CREST instructions (as appropriate)

11.00 a.m. on 26 November 2018

Admission and commencement of dealings in the New Ordinary Shares on AIM expected to commence

8.00 a.m. on 28 November 2018

Expected time and date on which CREST accounts to be credited with New Ordinary Shares in uncertificated form

On or after 8.00 a.m. on

28 November 2018

Expected date for despatch of definitive share certificates in respect of New Ordinary Shares to be issued in certificated form

By 5 December 2018

 

Notes:

 

1. Reference to times in this document is to London time unless otherwise stated.

2. Each of the times and dates above are indicative only and are subject to change. If any of the above times and/or dates change, the revised times and/or dates will be notified by the Company to the Shareholders by announcement through a Regulatory Information Service.

 

 

- ENDS -

 

For further information, please contact:

Imaginatik plc

Angus Forrest CEO

 

Via Alma

WH Ireland - Nominated Adviser

Mike Coe / Chris Savidge

 

Tel: 0117 945 3472

Peterhouse Capital Limited - Broker

Eran Zucker / Lucy Williams

 

Tel: +44 (0) 20 7220 9797

Alma PR

Caroline Forde / Robyn Fisher

 

Tel: +44 (0) 20 8004 4218

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEVFLFBVFFXFBX
Date   Source Headline
30th Dec 20193:10 pmRNSHalf-year Report
2nd Dec 20197:00 amRNSFinal Results
13th Nov 20197:00 amRNSAppointment of Joint Broker
28th Oct 20193:03 pmRNSDirector Declaration
27th Sep 201911:30 amRNSUpdate, Proposed Transaction and RPT
5th Sep 20194:18 pmRNSDirectorate Change
6th Aug 20197:31 amRNSRe Suspension and Update
6th Aug 20197:30 amRNSSuspension - Abal Group Plc
2nd Aug 20199:49 amRNSUpdate on suspension date
24th Jun 20199:11 amRNSUpdate on Board Changes
3rd May 20192:01 pmRNSHolding(s) in Company
3rd May 20199:00 amRNSPrice Monitoring Extension
2nd May 201911:55 amRNSHolding(s) in Company
1st May 201911:01 amRNSHolding(s) in Company
1st May 201910:58 amRNSHolding(s) in Company
29th Apr 201910:28 amRNSHolding(s) in Company
26th Apr 201911:52 amRNSHolding(s) in Company
5th Apr 20192:22 pmRNSHolding(s) in Company
1st Apr 20198:10 amRNSUpdate on Board changes
1st Mar 20197:00 amRNSUpdate and Directorate Change
5th Feb 201911:48 amRNSHolding(s) in Company
5th Feb 201910:08 amRNSCompletion of disposal
5th Feb 20198:23 amRNSHolding(s) in Company
31st Jan 20195:30 pmRNSImaginatik
31st Jan 201910:09 amRNSHolding(s) in Company
30th Jan 20199:38 amRNSHolding(s) in Company
28th Jan 201910:27 amRNSResult of GM
14th Jan 20197:00 amRNSIssue of Equity
10th Jan 20197:00 amRNSProposed sale of business and assets
13th Dec 20183:42 pmRNSHolding(s) in Company
12th Dec 201812:37 pmRNSResult of AGM
10th Dec 20183:47 pmRNSHolding(s) in Company
4th Dec 20182:10 pmRNSHolding(s) in Company
4th Dec 20189:23 amRNSHolding(s) in Company
3rd Dec 20183:01 pmRNSIssue of Equity
3rd Dec 20187:00 amRNSContract Award
28th Nov 20183:33 pmRNSHolding(s) in Company
28th Nov 20187:00 amRNSHolding(s) in Company
27th Nov 20187:00 amRNSResult of Open Offer
19th Nov 20187:00 amRNSHalf-year Report
16th Nov 20187:00 amRNSNotice of AGM
8th Nov 201812:52 pmRNSDirectorate Change
2nd Nov 20185:29 pmRNSHolding(s) in Company
2nd Nov 20187:00 amRNSOpen Offer
31st Oct 201812:37 pmRNSAdmission of new shares
26th Oct 20187:30 amRNSRestoration - Imaginatik plc
26th Oct 20187:00 amRNSAppointment of NOMAD and Completion of Placing
18th Oct 20187:00 amRNSCompany Update
1st Oct 20187:00 amRNSCompany Update
28th Sep 201811:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.